Astrazeneca (AZN) EV to EBITDA (2009 - 2026)
Astrazeneca's EV to EBITDA came in at 11.45 for Q3 2026, down 3.6% from 11.87 a year earlier and down 19.5% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) EV to EBITDA (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Astrazeneca reported EV to EBITDA of 10.59, down 3.3% year-over-year; for FY2025, it was 14.34, up 21.2% from FY2024.
- Going back by year, EV to EBITDA was 11.84 in FY2024 (-20.7%), 14.93 in FY2023 (-32.3%), 22.03 in FY2022 (-4.0%) and 22.95 in FY2021 (+54.8%).
- The Q3 2026 figure represents the lowest quarterly EV to EBITDA since Q3 2017.
- Year-over-year, EV to EBITDA increased in three of the last seven quarters, with growth averaging 0.8%.
- The fastest year-over-year change in EV to EBITDA over five years came in Q1 2022 (growth of 105.4%), and the weakest in Q2 2023 (a decline of 35.4%).
- Business Quant data shows AZN's EV to EBITDA at 14.22 (Q2 2026), 14.81 (Q1 2026) and 14.34 (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Vertex Pharmaceuticals | 139.96 Bn | 111.95 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 11.45 |
| Jun 30, 2026 | 14.22 |
| Mar 31, 2026 | 14.81 |
| Dec 31, 2025 | 14.34 |
| Sep 30, 2025 | 11.87 |
| Jun 30, 2025 | 11.55 |
| Mar 31, 2025 | 12.89 |
| Dec 31, 2024 | 11.85 |
| Sep 30, 2024 | 14.74 |
| Jun 30, 2024 | 14.51 |
| Mar 31, 2024 | 14.39 |
| Jun 30, 2023 | 18.20 |
| Mar 31, 2023 | 20.80 |
| Jun 30, 2022 | 28.17 |
| Mar 31, 2022 | 28.22 |
| Dec 31, 2021 | 22.96 |
| Sep 30, 2021 | 18.91 |
| Jun 30, 2021 | 16.04 |
| Mar 31, 2021 | 13.74 |
| Dec 31, 2020 | 14.84 |
API Access
Astrazeneca EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();